Preclinical research is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Updated 2026-04-23. Numbers and descriptions here follow the published literature rather than marketing material.
PPARδ is a nuclear receptor that influences transcription of genes involved in fatty acid oxidation, lipid transport, and energy homeostasis. GW501516 binds and activates this receptor with high selectivity relative to PPARα and PPARγ in laboratory assays. Activation alters expression of target genes in skeletal muscle, liver, and adipose tissue in animal models. The exact clinical consequences of these changes in humans remain incompletely characterized, and observed effects in animals do not establish therapeutic benefit or safety.
Published studies have examined GW501516 in animal models of obesity, insulin resistance, and exercise endurance. Early human trials reportedly ended, and development was discontinued after preclinical findings raised concerns about cancer in some rodent studies. Regulatory agencies have not approved cardarine for any medical use. Its availability through non-pharmaceutical channels raises questions about identity, purity, and legal status that are separate from its laboratory pharmacology. Those questions are often addressed through analytical testing rather than assumptions about product labels.
Cardarine is a common name for GW501516, also GW-1516, a synthetic compound developed as a peroxisome proliferator-activated receptor delta (PPARδ) agonist. It belongs to a class of agents that modulate gene transcription related to lipid and energy metabolism. The compound was studied in preclinical and early clinical research for metabolic and cardiovascular conditions, but it did not progress to approved therapeutic use. Its name appears in fitness and sports contexts despite not being approved as a drug.
In laboratory settings, cardarine is studied as a tool compound for probing PPARδ biology. Published experiments often use cell cultures, rodent models, or isolated tissues. Some investigations focus on metabolic effects, while others assess potential risks such as carcinogenicity observed in long-term animal studies. Because human trials are sparse, most knowledge comes from preclinical work and adverse event reports. Scientific literature frequently notes the gap between animal findings and human outcomes. The compound is not a dietary supplement and is not intended for human consumption.
Cardarine is a common name for GW501516, a synthetic compound developed in the 1990s through research collaborations involving GlaxoSmithKline. It belongs to a class of molecules known as peroxisome proliferator-activated receptor delta agonists. Early studies explored its effects on lipid metabolism and energy expenditure in animal models. The compound was never approved as a human medicine, and clinical development was discontinued. In the years since, it has appeared in fitness and bodybuilding communities as a performance-enhancing substance. Regulatory agencies classify it as an unapproved drug.
PPARδ is a nuclear receptor that regulates gene expression related to fatty acid oxidation, glucose homeostasis, and mitochondrial function. GW501516 binds to this receptor with high affinity and activates downstream signaling in skeletal muscle and other tissues. Animal studies reported increased endurance and altered fuel preference, but human data remain limited and inconsistent. The precise relationship between receptor activation and observed physiological changes is still an area of active investigation. Researchers have also examined whether the compound affects inflammation or cell proliferation. No approved therapeutic indication exists for cardarine.
| Property | Value | Notes |
|---|---|---|
| Chemical class | PPARδ agonist | Not an anabolic steroid. |
| Common synonyms | GW501516, GW-1516 | Cardarine is an informal name. |
| Appearance | White to off-white powder | Typical for research-grade solid. |
| Solubility class | Poorly soluble in water; soluble in some organic solvents | Such as DMSO or ethanol in laboratory settings. |
| Typical storage temperature | Cool, dry, protected from light | Specific conditions vary by supplier and form. |
=== Tenure === Upon the opening of the 118th United States Congress on January 3, 2023, Schmitt was sworn in by Senate president and Vice President Kamala Harris. He tweeted that he was honored to be the 2,000th senator to hold office in the history of the Senate. Schmitt was among the 31 Senate Republicans who voted against final passage of the Fiscal Responsibility Act of 2023, a bill to raise the debt ceiling. In February 2025, when NBC's Kristen Welker asked Schmitt the same question posed to Tulsi Gabbard during her Director of National Intelligence confirmation hearing—whether he would call Edward Snowden a traitor—he said many asking this oppose Gabbard because she would "reform and curb the excesses and the worst instincts of the intelligence community that at times has gone after presidential candidates". Later that month, after Trump called Ukrainian president Volodymyr Zelenskyy a "dictator" and said Ukraine was at fault for the Ukraine war, Schmitt said Zelenskyy should not be "openly criticizing" Trump and should "stop lecturing" him. Schmitt said Trump had spoken "a lot on the campaign trail" about "trying to negotiate a peace deal between Russia and Ukraine. ... He's a master negotiator, and I think he's going to get to a lasting peace." According to ABC News, Schmitt was the only Republican senator "to seemingly offer both support for Trump and the premise of his statements on Ukraine and Russia". At the start of the 119th Congress in 2025, Schmitt hired Nate Hochman as a staffer.
== PSP and cyanobacteria == PSP toxins (of which saxitoxin is the most ubiquitous) are produced in eukaryotic dinoflagellates and prokaryotic cyanobacteria (usually referred to as blue-green algae). Within the freshwater marine ecosystem, the largest contribution in the accumulation of PSP toxins derives from saxitoxin produced by cyanobacteria. The biosynthesis of saxitoxin is well-defined in cyanobacteria, while within dinoflagellates it remains mostly unknown. Cyanobacterial saxitoxin biosynthesis has been studied in radioisotope tracing experiments, and turns out to be highly complex, involving many steps, enzymes and chemical reactions. The starting reagent, L-arginine, goes through several chemical reactions (among which is a rare chemical reaction known as a Claisen condensation), going through four intermediates before resulting in saxitoxin. The Australian freshwater mussel Alathyria condola is highly susceptible to neurotoxin accumulation. After two to three days of exposure to the cyanobacterium Anabaena circinalis it may contain upwards of 80 micrograms of neurotoxins per 100 grams of mussel, a level high enough to cause significant health risks to humans.
== Reactions == The entire process converts two amino groups, one from NH+4 and one from aspartate, and a carbon atom from HCO−3, to the relatively nontoxic excretion product urea. This occurs at the cost of four "high-energy" phosphate bonds (3 ATP hydrolyzed to 2 ADP and one AMP). The conversion from ammonia to urea happens in five main steps. The first is needed for ammonia to enter the cycle and the following four are all a part of the cycle itself. To enter the cycle, ammonia is converted to carbamoyl phosphate. The urea cycle consists of four enzymatic reactions: one mitochondrial and three cytosolic. This uses 6 enzymes.
On 15 July, three more insurgents were killed under Operation Shaban bringing the death toll so far to 126 whereas a VBIED attack on the Miryan Police Station in Bannu District was foiled before it could reach the target, however one cop was killed and six were injured, four civilians were also wounded, later it was reported that four IMP insurgents were killed during the attack and that the suicide bomber was an Afghan from Paktia Province. An attack on a military post in Shalozan Tangi area of Kurram District left seven soldiers injured as well as multiple casualties among the attackers. Four dead bodies of active duty and ex-security personnel were also recovered from Harnai District while three explosions were also reported at a Mari Gas Company site near Koh e Khalifat. On 16 July, an ambush on a police convoy in Upper Dir District left three policemen dead and 15 injured, five insurgents were also killed in an operation in Laram area of Lower Dir District. Three more insurgents were also killed under Operation Shaban bringing the toll to 129. A suicide attack on a military post in Wana was foiled with four insurgents being killed. A military operation was initiated in multiple areas of Bannu District with a facilitator of the previous day's VBIED attack being captured. On 17 July, ISPR claimed that Pakistani forces had killed 24 TTP insurgents in Bannu District during comprehensive operations while IMP issued a warning against travel in Bannu District as it had planted landmines during the military operation.
The G-spot is analogous to the base of the penis and has additionally been theorized, with the sentiment from researcher Amichai Kilchevsky that because female fetal development is the "default" state in the absence of substantial exposure to male hormones and therefore the penis is essentially a clitoris enlarged by such hormones, there is no evolutionary reason why females would have an entity in addition to the clitoris that can produce orgasms. The general difficulty of achieving orgasms vaginally, which is a predicament that is likely due to nature easing the process of childbearing by drastically reducing the number of vaginal nerve endings, challenge arguments that vaginal orgasms help encourage sexual intercourse to facilitate reproduction. Supporting a distinct G-spot, however, is a study by Rutgers University, published in 2011, which was the first to map the female genitals onto the sensory portion of the brain; the scans indicated that the brain registered distinct feelings between stimulating the clitoris, the cervix and the vaginal wall – where the G-spot is reported to be – when several women stimulated themselves in a functional magnetic resonance machine. Barry Komisaruk, head of the research findings, stated that he feels that "the bulk of the evidence shows that the G-spot is not a particular thing" and that it is "a region, it's a convergence of many different structures".
Sources: en.wikipedia.org
In 1899 he was appointed assistant professor at West Virginia University. He moved to the McLean Hospital Boston in 1900 as a research biochemist, eventually moving to Harvard Medical School in 1907 as an associate professor of biological chemistry, becoming the Hamilton Kuhn Professor of Biological Chemistry and Molecular Pharmacology in 1909. Together with Vintilă Ciocâlteu Otto Folin designed the Folin-Ciocalteu reagent to detect polyphenols. In 1920, he co-developed with Hsien Wu the Folin-Wu method of assaying glucose in protein-free filtrates of blood. Folin was elected the president of the American Society of Biological Chemists (now the American Society for Biochemistry and Molecular Biology) in 1909. He was a member of the editorial board of the Journal of Biological Chemistry. He was elected to the National Academy of Sciences and was awarded the Carl Wilhelm Scheele Medal of the Swedish Chemical Society in 1930.
== Medical uses == Hydroxychloroquine treats rheumatic disorders such as systemic lupus erythematosus, rheumatoid arthritis, and porphyria cutanea tarda, and certain infections such as Q fever and certain types of malaria. It is considered the first-line treatment for systemic lupus erythematosus. Certain types of malaria, resistant strains, and complicated cases require different or additional medication. Hydroxychloroquine blocks the effects of some chemicals released in autoimmune diseases, and is used to treat inflammatory conditions. It is widely used to treat primary Sjögren syndrome but does not appear to be effective. Hydroxychloroquine is widely used in the treatment of post-Lyme arthritis. It may have both an anti-spirochete activity and an anti-inflammatory activity, similar to the treatment of rheumatoid arthritis.
=== Precision medicine === Graphene oxide has been studied for its promising uses in a wide variety of nanomedical applications including tissue engineering, cancer treatment, medical imaging, and drug delivery. Its physiochemical properties allow for a structure to regulate the behaviour of stem cells, with the potential to assist in the intracellular delivery of DNA, growth factors, and synthetic proteins that could allow for the repair and regeneration of muscle tissue. Due to its unique behaviour in biological environments, GO has also been proposed as a novel material in early cancer diagnosis. It has also been explored for its uses in vaccines and immunotherapy, including as a dual-use adjuvant and carrier of biomedical materials. In September 2020, researchers at the Shanghai National Engineering Research Center for Nanotechnology in China filed a patent for use of graphene oxide in a recombinant vaccine under development against SARS-CoV-2.
=== Sequence-based methods === Prime, NetMHCpan, MHCnuggets, MHCflurry, DeepNeo, and BigMHC are among the most popular methods to predict peptide-MHC immunogenicity from protein amino acid sequences. They essentially parse the protein sequences as text data, using 1-dimensional convolutional neural networks, recurrent neural networks, or Transformer models.
Sources: en.wikipedia.org
Cardarine is commonly known as GW501516 or GW-1516. These names refer to the same synthetic compound. It is not a brand-name approved medicine.
No, cardarine is not a steroid. It is classified as a PPARδ agonist. Its structure and receptor target differ from anabolic steroids.
No regulatory agency has approved cardarine as a medicine. It was investigated in early research but development was discontinued. It is not available as a prescription drug.
Cardarine is a common name for GW501516, a synthetic PPARδ agonist developed for research. It has not been approved as a medication in any country. It is classified as an unapproved drug and a prohibited substance in sport.